Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

The treatment successfully lowered testosterone levels and reduced symptoms.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Finasteride may improve prostate cancer treatment outcomes.

Dutasteride and finasteride affect different cell types differently.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.